Oriflame announced its financial results for the fourth quarter and full year 2024. Sales in the fourth quarter decreased by 15% year over year to $183.9 million with an adjusted EBITDA of $5.78 million.
Oriflame, with the support of the af Jochnick family and investors representing more than 80% of its bonds, announced a comprehensive recapitalization. With this move, Oriflame secures substantial debt reduction and allows for strategic investments that will fund the next stage of growth.
Oriflame will now donate 50p (approximately $0.62) from every sale of its Tender Care Multi-Purpose Balm in the UK and Ireland to the support the nonprofit’s work to provide education and a safe learning space for children at risk.
Oriflame announced it will transition its European production processes from its current factory in Poland to a select network of high-end European manufacturers.
Oriflame reported its financial results for Q3 2024. Net Euro sales declined 19% in the quarter to $141.3 million with an adjusted EBITDA of $5.83 million.
Oriflame announced its financial results for the first half of 2024 and the quarter ending June 30, 2024. Sales during the first half of the year declined by 22% when compared to the previous year.
Swedish beauty brand Oriflame announced a partnership with Active Ants, which helps brands streamline their order fulfillment process through automation, as it launches a new warehouse in the UK. This collaboration is expected to not only boost order accuracy to a rate of 99.9%, but will also increase efficiency, processing orders 50% faster than traditional methods.
Oriflame Nigeria hosted its annual 2024 Director Seminar at the Eko Hotels and Suites, welcoming CEO and President Anna Malmhake for her inaugural visit to the country.
Oriflame released its 2023 Sustainability Report, revealing significant strides in its efforts to address its own carbon footprint and environmental impact.
Oriflame released its financial results for the fourth quarter and full year 2023. Revenue during the fourth quarter fell 25% to $215 million with an adjusted EBITDA of $6.7 million. Adjusted operating profit was $300,000.
Oriflame announced a new collaborative agreement with Revieve, an enterprise-grade beauty and wellness technology platform, to offer customers a digital skincare solution that provides product recommendations and skincare advice based on the diagnostic analysis of more than 120 skin metrics. This new AI Skincare Advisor is expected to help consumers discover personalized beauty products that meet the needs of their unique skin type and concerns.
Oriflame released its interim management statement for the first three quarters of the year, ending September 30, 2023. During the first nine months of the year, the company saw a 17% decrease in Euro sales to $585.2 million. Adjusted EBITDA during this time was $34.7 million.